Growth Metrics

Pfizer (PFE) FCF Payout Ratio (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 106.65%
Dec 31, 2025 -11.11%
Sep 28, 2025 129.98%
Jun 29, 2025 -248.07%
Sep 29, 2024 279.75%
Jun 30, 2024 -116.02%
Mar 31, 2024 1,013.81%
Dec 31, 2023 -36.91%
Oct 1, 2023 180.16%
Jul 2, 2023 -103.46%
Oct 2, 2022 20.74%
Jul 3, 2022 -20.68%
Oct 3, 2021 27.52%
Jul 4, 2021 -62.79%
Sep 27, 2020 146.79%
Jun 28, 2020 -58.03%
Mar 29, 2020 99.89%
Dec 31, 2019 21.52%
Sep 29, 2019 -45.90%
Jun 30, 2019 -43.15%
Mar 31, 2019 339.07%
Dec 31, 2018 -263.28%
Sep 30, 2018 -27.17%
Jul 1, 2018 -54.33%
Apr 1, 2018 325.84%
Dec 31, 2017 -30.01%
Oct 1, 2017 -37.60%
Jul 2, 2017 -56.88%
Apr 2, 2017 366.27%
Dec 31, 2016 -19.56%
Oct 2, 2016 -25.55%
Jul 3, 2016 -53.82%
Apr 3, 2016 205.04%
Dec 31, 2015 10.42%
Sep 27, 2015 -18.86%
Jun 28, 2015 -88.71%
Mar 29, 2015 1,175.69%
Dec 31, 2014 -20.68%
Sep 28, 2014 -9.49%
Jun 29, 2014 -30.78%
Mar 30, 2014 114.75%
Dec 31, 2013 3.54%
Sep 29, 2013 -42.67%
Jun 30, 2013 -40.26%
Mar 31, 2013 127.18%
Dec 31, 2012 5.08%
Sep 30, 2012 -21.05%
Jul 1, 2012 -33.08%
Apr 1, 2012 100.34%
Dec 31, 2011 -16.03%
Oct 2, 2011 37.51%
Jul 3, 2011 -21.87%
Apr 3, 2011 33.99%
Dec 31, 2010 11.62%
Oct 3, 2010 -29.86%
Jul 4, 2010 259.73%
Apr 4, 2010 -174.37%
Dec 31, 2009 4.53%
Sep 27, 2009 10.65%
Jun 28, 2009 -65.90%